Target Price | $98.08 |
Price | $72.02 |
Potential |
36.18%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Globus Medical, Inc. Class A 2026 .
The average Globus Medical, Inc. Class A target price is $98.08.
This is
36.18%
register free of charge
$115.00
59.68%
register free of charge
$82.00
13.86%
register free of charge
|
|
A rating was issued by 17 analysts: 13 Analysts recommend Globus Medical, Inc. Class A to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Globus Medical, Inc. Class A stock has an average upside potential 2026 of
36.18%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 2.52 | 2.68 |
60.62% | 6.41% | |
EBITDA Margin | 19.30% | 32.42% |
12.64% | 67.94% | |
Net Margin | 4.09% | 15.45% |
56.36% | 277.67% |
14 Analysts have issued a sales forecast Globus Medical, Inc. Class A 2025 . The average Globus Medical, Inc. Class A sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Globus Medical, Inc. Class A EBITDA forecast 2025. The average Globus Medical, Inc. Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Globus Medical, Inc. Class A Analysts have issued a net profit forecast 2025. The average Globus Medical, Inc. Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.75 | 3.02 |
29.91% | 302.67% | |
P/E | 23.89 | |
EV/Sales | 3.56 |
8 Analysts have issued a Globus Medical, Inc. Class A forecast for earnings per share. The average Globus Medical, Inc. Class A EPS is
This results in the following potential growth metrics and future valuations:
Globus Medical, Inc. Class A...
Analyst | Rating | Action | Date |
---|---|---|---|
Truist Securities |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
Needham |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Feb 24 2025 |
Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Feb 24 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Needham |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Analyst Rating | Date |
---|---|
Locked
Truist Securities:
Locked
➜
Locked
|
Mar 18 2025 |
Locked
Needham:
Locked
➜
Locked
|
Mar 18 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Feb 24 2025 |
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Feb 24 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Feb 21 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 21 2025 |
Locked
Needham:
Locked
➜
Locked
|
Feb 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.